China · Delayed Price · Currency is CNY Hualan Biological Vaccine Statistics
Total Valuation
SHE:301207 has a market cap or net worth of CNY 11.85 billion. The enterprise value is 9.06 billion.
| Market Cap | 11.85B |
| Enterprise Value | 9.06B |
Important Dates
The last earnings date was Saturday, March 28, 2026.
| Earnings Date | Mar 28, 2026 |
| Ex-Dividend Date | Oct 27, 2025 |
Share Statistics
SHE:301207 has 595.00 million shares outstanding. The number of shares has decreased by -0.51% in one year.
| Current Share Class | 595.00M |
| Shares Outstanding | 595.00M |
| Shares Change (YoY) | -0.51% |
| Shares Change (QoQ) | -0.14% |
| Owned by Insiders (%) | 0.26% |
| Owned by Institutions (%) | 2.95% |
| Float | 93.43M |
Valuation Ratios
The trailing PE ratio is 64.77 and the forward PE ratio is 55.31.
| PE Ratio | 64.77 |
| Forward PE | 55.31 |
| PS Ratio | 9.85 |
| PB Ratio | 2.08 |
| P/TBV Ratio | 2.08 |
| P/FCF Ratio | 34.10 |
| P/OCF Ratio | 33.17 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 39.17, with an EV/FCF ratio of 26.08.
| EV / Earnings | 49.54 |
| EV / Sales | 7.54 |
| EV / EBITDA | 39.17 |
| EV / EBIT | 100.39 |
| EV / FCF | 26.08 |
Financial Position
The company has a current ratio of 3.92
| Current Ratio | 3.92 |
| Quick Ratio | 3.70 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 35.40 |
Financial Efficiency
Return on equity (ROE) is 3.12% and return on invested capital (ROIC) is 5.11%.
| Return on Equity (ROE) | 3.12% |
| Return on Assets (ROA) | 0.79% |
| Return on Invested Capital (ROIC) | 5.11% |
| Return on Capital Employed (ROCE) | 1.58% |
| Weighted Average Cost of Capital (WACC) | 8.50% |
| Revenue Per Employee | 1.61M |
| Profits Per Employee | 244,545 |
| Employee Count | 748 |
| Asset Turnover | 0.17 |
| Inventory Turnover | 1.68 |
Taxes
In the past 12 months, SHE:301207 has paid 4.87 million in taxes.
| Income Tax | 4.87M |
| Effective Tax Rate | 2.59% |
Stock Price Statistics
The stock price has increased by +27.47% in the last 52 weeks. The beta is 0.77, so SHE:301207's price volatility has been lower than the market average.
| Beta (5Y) | 0.77 |
| 52-Week Price Change | +27.47% |
| 50-Day Moving Average | 20.14 |
| 200-Day Moving Average | 19.64 |
| Relative Strength Index (RSI) | 51.29 |
| Average Volume (20 Days) | 6,256,825 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHE:301207 had revenue of CNY 1.20 billion and earned 182.92 million in profits. Earnings per share was 0.31.
| Revenue | 1.20B |
| Gross Profit | 877.36M |
| Operating Income | 90.27M |
| Pretax Income | 187.79M |
| Net Income | 182.92M |
| EBITDA | 231.35M |
| EBIT | 90.27M |
| Earnings Per Share (EPS) | 0.31 |
Balance Sheet
The company has 2.78 billion in cash and n/a in debt, with a net cash position of 2.78 billion or 4.68 per share.
| Cash & Cash Equivalents | 2.78B |
| Total Debt | n/a |
| Net Cash | 2.78B |
| Net Cash Per Share | 4.68 |
| Equity (Book Value) | 5.70B |
| Book Value Per Share | 9.59 |
| Working Capital | 3.27B |
Cash Flow
In the last 12 months, operating cash flow was 357.13 million and capital expenditures -9.70 million, giving a free cash flow of 347.43 million.
| Operating Cash Flow | 357.13M |
| Capital Expenditures | -9.70M |
| Depreciation & Amortization | 141.22M |
| Net Borrowing | -300.00M |
| Free Cash Flow | 347.43M |
| FCF Per Share | 0.58 |
Margins
Gross margin is 72.96%, with operating and profit margins of 7.51% and 15.21%.
| Gross Margin | 72.96% |
| Operating Margin | 7.51% |
| Pretax Margin | 15.62% |
| Profit Margin | 15.21% |
| EBITDA Margin | 19.24% |
| EBIT Margin | 7.51% |
| FCF Margin | 28.89% |
Dividends & Yields
This stock pays an annual dividend of 1.60, which amounts to a dividend yield of 8.04%.
| Dividend Per Share | 1.60 |
| Dividend Yield | 8.04% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 4 |
| Payout Ratio | 277.66% |
| Buyback Yield | 0.51% |
| Shareholder Yield | 8.55% |
| Earnings Yield | 1.54% |
| FCF Yield | 2.93% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on June 7, 2023. It was a forward split with a ratio of 1.5.
| Last Split Date | Jun 7, 2023 |
| Split Type | Forward |
| Split Ratio | 1.5 |
Scores
SHE:301207 has an Altman Z-Score of 7 and a Piotroski F-Score of 4.
| Altman Z-Score | 7 |
| Piotroski F-Score | 4 |